Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis

JAMA Neurol. 2018 Jul 1;75(7):892-895. doi: 10.1001/jamaneurol.2018.0805.

Authors

Jiraporn Jitprapaikulsan^{1

2}, A Sebastian Lopez Chiriboga¹, Eoin P Flanagan^{1

3}, James P Fryer², Andrew McKeon^{1

2

3}, Brian G Weinshenker^{1

3}, Sean J Pittock^{1

2

3}

Affiliations

¹ Department of Neurology, Mayo Clinic, Rochester, Minnesota.
² Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
³ Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota.

Abstract

This cohort study presents serological data with regard to 2 novel glial targets (myelin oligodendrocyte glycoprotein and glial fibrillary acidic protein) in recurrent longitudinally extensive transverse myelitis.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Adult
Autoantibodies / immunology*
Cohort Studies
Female
Glial Fibrillary Acidic Protein / immunology*
Humans
Immunoglobulin G / immunology*
Male
Middle Aged
Myelin-Oligodendrocyte Glycoprotein / immunology*
Myelitis, Transverse / immunology*
Serologic Tests
Young Adult

Substances

Autoantibodies
Glial Fibrillary Acidic Protein
Immunoglobulin G
Myelin-Oligodendrocyte Glycoprotein